NCT01434381View on ClinicalTrials.gov

Initial Study of Malaria Vaccine Pfs25-EPA/Alhydrogel(Registered Trademark)

PHASE1CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

August 31, 2011

Primary Completion Date

August 31, 2013

Study Completion Date

August 31, 2013

Conditions
Malaria
Interventions
BIOLOGICAL

Pfs25-EPA/Alhydrogel

Trial Locations (1)

21205

Johns Hopkins University, Baltimore

All Listed Sponsors
lead

National Institute of Allergy and Infectious Diseases (NIAID)

NIH

NCT01434381 - Initial Study of Malaria Vaccine Pfs25-EPA/Alhydrogel(Registered Trademark) | Biotech Hunter | Biotech Hunter